Literature DB >> 8684541

Diffuse mesangial sclerosis: a unique type of congenital and infantile nephrotic syndrome.

S Ozen1, K Tinaztepe.   

Abstract

Clinical and pathological findings in four Turkish infants with isolated diffuse mesangial sclerosis (DMS) are presented. All the patients were offsprings of consanguineous marriages and two had similarly affected sibs indicating an autosomal recessive inheritance. The onset of the nephrotic syndrome was at 7, 17, 11 and 3 months of age. They all died in a state of renal failure complicated by infections at the ages of 11, 33, 13 and 5 months. DMS was diagnosed at postmortem examination in all. Fluorescence-microscopical studies in all and an electron-microscopical study in one revealed nonspecific findings. The shorter survival in three of the cases was thought to be due to intervening infections. The variation of the clinical features along with the fluorescence and electron-microscopical findings are consistent with the previously mentioned heterogeneous aspect of DMS.

Entities:  

Mesh:

Year:  1996        PMID: 8684541     DOI: 10.1159/000188856

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  3 in total

1.  Evolutive study of children with diffuse mesangial sclerosis.

Authors:  Ana Pilar Nso Roca; Antonia Peña Carrión; Marta Benito Gutiérrez; Carmen García Meseguer; Araceli García Pose; Mercedes Navarro
Journal:  Pediatr Nephrol       Date:  2008-12-10       Impact factor: 3.714

2.  WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis.

Authors:  Y Yang; C Jeanpierre; G R Dressler; M Lacoste; P Niaudet; M C Gubler
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

3.  Clinico-pathological correlations of congenital and infantile nephrotic syndrome over twenty years.

Authors:  Jameela A Kari; Giovanni Montini; Detlef Bockenhauer; Eileen Brennan; Lesley Rees; Richard S Trompeter; Kjell Tullus; William Van't Hoff; Aoife Waters; Emma Ashton; Nicholas Lench; Neil J Sebire; Stephen D Marks
Journal:  Pediatr Nephrol       Date:  2014-06-06       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.